Stock Price
1.03
Daily Change
0.01 0.98%
Monthly
31.29%
Yearly
-44.32%
Q2 Forecast
1.00

RedHill Biopharma reported $22.29M in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
Cara Therapeutics USD 11.04M 2K Dec/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
Cronos Group USD 42.42M 5.77M Mar/2026
RedHill Biopharma USD 22.29M 64K Jun/2025